CO5170470A1 - Relajantes neuromusculares de aralquilo y aralquenilo mono-aciloxi sustituidos - Google Patents

Relajantes neuromusculares de aralquilo y aralquenilo mono-aciloxi sustituidos

Info

Publication number
CO5170470A1
CO5170470A1 CO00005913A CO00005913A CO5170470A1 CO 5170470 A1 CO5170470 A1 CO 5170470A1 CO 00005913 A CO00005913 A CO 00005913A CO 00005913 A CO00005913 A CO 00005913A CO 5170470 A1 CO5170470 A1 CO 5170470A1
Authority
CO
Colombia
Prior art keywords
substituted
mono
aralquenilo
aciloxi
aralquilo
Prior art date
Application number
CO00005913A
Other languages
English (en)
Inventor
Lee Chingmuh
Gyermek Laszlo
Moon Cho Young
Original Assignee
Newlaxant Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newlaxant Llc filed Critical Newlaxant Llc
Publication of CO5170470A1 publication Critical patent/CO5170470A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)

Abstract

Un compuesto CARACTERIZADO porque tiene la fórmula general a<EMI FILE="00005913_1" ID="1" IMF=JPEG >o la Fórmula general b<EMI FILE="00005913_2" ID="2" IMF=JPEG >donde R1 y R1´ son aralquilo o aralquenilo mono-aciloxi sustituido; R2 y R2´ son alquilo, o alquinilo; A es alcanodicarbonilo, alquenodicarbonilo, alquinodicarbonilo, cicloalcanodicarbonilo, cicloalquenodicarbonilo, bicicloalcanodicarbonilo, bicicloalquenodicarbonilo, poIicicloalcanodicarbonilo, poIicicloalquenodicarbonilo o dicarbonilo aromático, normales o sustituidos; n es 0, 1 ó 2; m es 0, 1 ó 2; p es 0, 1 ó 2; R3 y R3´ son H, CH3 ó alquilo inferior; R4 y R4´ son H, CH3 ó alquilo inferior; ó R3 y R4 juntos forman -CH=CH-, -(CH2)h-Y-(CH2)k-,<EMI FILE="00005913_3" ID="3" IMF=JPEG >
CO00005913A 1999-02-01 2000-02-01 Relajantes neuromusculares de aralquilo y aralquenilo mono-aciloxi sustituidos CO5170470A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11839299P 1999-02-01 1999-02-01

Publications (1)

Publication Number Publication Date
CO5170470A1 true CO5170470A1 (es) 2002-06-27

Family

ID=22378296

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00005913A CO5170470A1 (es) 1999-02-01 2000-02-01 Relajantes neuromusculares de aralquilo y aralquenilo mono-aciloxi sustituidos

Country Status (21)

Country Link
EP (1) EP1150673A4 (es)
JP (1) JP2002535366A (es)
KR (1) KR20010108125A (es)
CN (1) CN1338934A (es)
AR (1) AR022472A1 (es)
AU (1) AU2634900A (es)
BR (1) BR0007863A (es)
CA (1) CA2360790A1 (es)
CO (1) CO5170470A1 (es)
CZ (1) CZ20012780A3 (es)
HK (1) HK1039455A1 (es)
HU (1) HUP0200413A3 (es)
IL (1) IL144249A0 (es)
MX (1) MXPA01007783A (es)
NO (1) NO20013741L (es)
NZ (1) NZ513064A (es)
PE (1) PE20001593A1 (es)
PL (1) PL349099A1 (es)
TR (1) TR200102196T2 (es)
WO (1) WO2000044377A1 (es)
ZA (1) ZA200105882B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746964A (en) * 1953-11-02 1956-05-22 Lakeside Lab Inc Dicarboxylic acid esters of nu-alkyl-3-hydroxypiperidine and salts thereof
AT292702B (de) * 1968-12-29 1971-09-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von neuen N-Metyl-piperidin-Derivaten sowie der Säureadditionssalze und der Oniumderivate dieser Verbindungen
US5494898A (en) * 1991-02-13 1996-02-27 Ohmeda Pharmaceutical Products Division Inc. Peptide skeletal muscle relaxants
US5990124A (en) * 1997-10-24 1999-11-23 Gyermek; Laszlo Neuromuscular relaxants

Also Published As

Publication number Publication date
KR20010108125A (ko) 2001-12-07
CZ20012780A3 (cs) 2002-01-16
IL144249A0 (en) 2002-05-23
EP1150673A4 (en) 2002-04-24
JP2002535366A (ja) 2002-10-22
HUP0200413A3 (en) 2002-11-28
HUP0200413A2 (en) 2002-06-29
HK1039455A1 (zh) 2002-04-26
ZA200105882B (en) 2003-02-18
NZ513064A (en) 2003-08-29
AR022472A1 (es) 2002-09-04
EP1150673A1 (en) 2001-11-07
PL349099A1 (en) 2002-07-01
NO20013741D0 (no) 2001-07-31
AU2634900A (en) 2000-08-18
NO20013741L (no) 2001-09-19
WO2000044377A1 (en) 2000-08-03
CN1338934A (zh) 2002-03-06
TR200102196T2 (tr) 2002-01-21
PE20001593A1 (es) 2001-01-16
BR0007863A (pt) 2001-11-06
CA2360790A1 (en) 2000-08-03
MXPA01007783A (es) 2002-08-20

Similar Documents

Publication Publication Date Title
NL350077I2 (nl) Cyprosulfamide
DK0984778T3 (da) Neuropeptid-Y-ligander
CO5140093A1 (es) Epotilonas c 21 modificadas
ID28026A (id) Senyawa-senyawa 1,2,3,4-tetrahidrokuinolina-tersubstitusi-4-karboksiamino-2 sebagai penghambat-penghambat cetp
ATE245636T1 (de) Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten
NO982872L (no) Forbindelser med veksthormonfrigjörende egenskaper
ATE248824T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
ATE268806T1 (de) Lichtemittierende dendrimere
AR248397A1 (es) N-(fenil)pirazol-4-carboamidas novedosas utiles como fungicidas, composiciones fungicidas que las contienen y metodo para controlar enfermedades de plantas por hongos mediante dichos compuestos.
ATE210163T1 (de) Triazinpolymere und deren verwendung in elektrolumineszierenden anordnungen
ATE230392T1 (de) Amidinophenyl-pyrrolidine, -pyrroline und - isoxazolidine und ihre derivate
ATE407155T1 (de) Pyridin-imin polymerisationskatalysator
DE69920888D1 (de) Disubstituierte pyrazoline und triazoline als faktor xa inhibitoren
SE9702773D0 (sv) Novel compounds
TR200201684T2 (tr) Fenilpiperazinil türevleri
EP1029860A4 (en) BENZOFURAN DERIVATIVES
TR199900363T2 (xx) NK1 ve NK2 antagonistleri olarak asilaminoalkenilen-amid t�revleri.
TW427979B (en) A condensed piperidine compound
BG105847A (en) Calcilytic compounds
CO5400148A1 (es) Derivados de pirazoles que son antagonistas de cck-1
BG104232A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazozocyn-10-ols, method for their preparation and application as medicamentous forms
ES2172029T3 (es) 3-amino-1-cianofenil-uracilos.
BG103789A (en) Fungicidal compositions
DK1204659T3 (da) Serotonerge benzofuraner
CO5170470A1 (es) Relajantes neuromusculares de aralquilo y aralquenilo mono-aciloxi sustituidos

Legal Events

Date Code Title Description
FC Application refused